![]() |
Volumn 39, Issue , 1999, Pages 295-312
|
Cyclins and cell cycle checkpoints
|
Author keywords
[No Author keywords available]
|
Indexed keywords
7 HYDROXYSTAUROSPORINE;
ANTIMETABOLITE;
ANTINEOPLASTIC AGENT;
CYCLIN A;
CYCLIN D;
CYCLIN DEPENDENT KINASE;
CYCLIN E;
DNA TOPOISOMERASE INHIBITOR;
PROTEIN P16;
PROTEIN P21;
PROTEIN P53;
RAS PROTEIN;
REGULATOR PROTEIN;
RETINOBLASTOMA PROTEIN;
TRANSCRIPTION FACTOR E2F;
TUBULIN;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
CELL CYCLE;
DNA DAMAGE;
DNA REPLICATION;
DNA SYNTHESIS INHIBITION;
ENZYME INHIBITION;
HUMAN;
MICROTUBULE ASSEMBLY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS;
REVIEW;
ANIMALS;
CELL CYCLE;
CELL PHYSIOLOGY;
CYCLIN-DEPENDENT KINASES;
CYCLINS;
HUMANS;
NEOPLASMS;
EUKARYOTA;
|
EID: 0032924467
PISSN: 03621642
EISSN: None
Source Type: Book Series
DOI: 10.1146/annurev.pharmtox.39.1.295 Document Type: Review |
Times cited : (603)
|
References (9)
|